AdvanSource Biomaterials is an ISO certified materials technology company, specializing in medical grade materials for long and short term applications. The Company's materials are USP Class VI and are available in both standard as well as custom formulations - offering tailored mechanical characteristics in order to enhance and optimize device design and functionality. AdvanSource Biomaterials develops innovative biomaterials which may be used as structural engineering polymers, co-extrusion layers or as specialized coatings for a wide variety of material substrates.
TypePublic
HQWilmington, US
Founded1998
Size (employees)15 (est)-21%
Websiteadvbiomaterials.com
AdvanSource Biomaterials was founded in 1998 and is headquartered in Wilmington, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

AdvanSource Biomaterials Office Locations

AdvanSource Biomaterials has an office in Wilmington
Wilmington, US (HQ)
235 Andover St
Show all (1)
Report incorrect company information

AdvanSource Biomaterials Financials and Metrics

AdvanSource Biomaterials Revenue

Embed Graph
AdvanSource Biomaterials's revenue was reported to be $2.92 m in FY, 2018
USD

Revenue (Q1, 2019)

589 k

Gross profit (Q1, 2019)

416 k

Gross profit margin (Q1, 2019), %

70.6%

Net income (Q1, 2019)

(91 k)

EBIT (Q1, 2019)

3 k

Market capitalization (18-Sep-2018)

1.7 k

Cash (30-Jun-2018)

124 k

EV

167.7 k
AdvanSource Biomaterials's current market capitalization is $1.7 k.
Annual
USDFY, 2017FY, 2018

Revenue

2.3 m2.9 m

Cost of goods sold

853 k799 k

Gross profit

1.4 m2.1 m

Gross profit Margin, %

63%73%
Quarterly
USDQ3, 2014Q1, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q2, 2018Q1, 2019

Revenue

685 k621 k1.2 m1 m592 k800 k467 k702 k589 k

Cost of goods sold

168 k228 k322 k305 k242 k259 k174 k216 k173 k

Gross profit

517 k393 k849 k736 k350 k541 k293 k486 k416 k

Gross profit Margin, %

75%63%73%71%59%68%63%69%71%
Annual
USDFY, 2017FY, 2018

Cash

27 k120 k

Inventories

189 k297 k

Current Assets

454 k991 k

PP&E

1.9 m1.8 m
Quarterly
USDQ3, 2014Q1, 2015Q2, 2018Q1, 2019

Cash

108 k133 k288 k124 k

Inventories

378 k150 k289 k340 k

Current Assets

745 k471 k998 k877 k

PP&E

2.2 m2.1 m1.9 m1.8 m
Annual
USDFY, 2017FY, 2018

Net Income

(509 k)(202 k)

Depreciation and Amortization

57 k52 k

Accounts Payable

174 k94 k

Purchases of PP&E

(10 k)
Quarterly
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q3, 2017Q1, 2019

Net Income

41 k(132 k)337 k181 k(111 k)37 k(172 k)(91 k)

Depreciation and Amortization

43 k13 k

Accounts Payable

(84 k)247 k298 k327 k217 k186 k305 k336 k18 k

Purchases of PP&E

(24 k)
USDY, 2018

EV/EBIT

55.9 x

Financial Leverage

-4.7 x
Show all financial metrics
Report incorrect company information

AdvanSource Biomaterials Company Life and Culture

Report incorrect company information